CATEGORIES

Industry News

LATEST

TRENDING

EDITORS CHOICE

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

Alterity and UniQuest Partner to Reverse Bacterial Resistance to Antibiotics

Alterity has secured the worldwide exclusive right to patented technology to develop and commercialise therapies that re-sensitise bacteria to antibiotics

Questions About FDA Protection From Dangerous Beauty Products

Looking good and feeling healthy are two things most of us would agree we want, and we should act to ensure both, but are we safe from unmonitored products?

How Dare You Criticize Psychiatrists Who Praise Studies of Psychedelics As Antidepressants?

All claims about treatments affecting human health and well-being should be subject to robust review. That review requires someone to facilitate criticism, locate qualified critics, and bring them into the discussion.